Portfolio Holdings Detail for ISIN IE000D3BWBR2
Stock Name / FundiShares S&P 500 Swap UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity Type
Entity LEI 549300VML6THE3JJOS76
ETF TickerI50D(USD) Euronext Amsterdam

Holdings detail for ALNY

Stock NameAlnylam Pharmaceuticals Inc
TickerALNY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS02043Q1076
LEI529900S3ZI14OWRJII50

Show aggregate ALNY holdings

News associated with ALNY

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $500.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by Royal Bank Of Canada from $435.00 to $500.00 in a report issued on Friday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. ALNY has been the topic of several other reports. The Goldman Sachs Group boosted their price […] - 2025-09-22 02:32:43
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $520.00 Price Target at Bank of America
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective raised by Bank of America from $453.00 to $520.00 in a research report report published on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. A number of other equities analysts have also weighed in on ALNY. Oppenheimer upgraded shares […] - 2025-09-18 04:26:54
The Goldman Sachs Group Forecasts Strong Price Appreciation for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by The Goldman Sachs Group from $504.00 to $566.00 in a report published on Tuesday,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on the stock. Chardan Capital lifted […] - 2025-09-17 03:14:44
Brokerages Set Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) PT at $421.28
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-seven analysts that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and twenty-three have issued a buy recommendation on the company. The average 1 year target price […] - 2025-09-15 02:47:58
Alnylam Announces Pricing Of Upsized Offering Of $575 Mln Convertible Senior Notes Due 2028
(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced the pricing of its private offering of $575 million aggregate principal amount of 0.00% convertible senior notes due 2028. The size of the offering was increased from the previously announced offering of $500 million aggre - 2025-09-10 00:33:28
Alnylam Pharma Commences Private Offering Of $500 Mln Of Convertible Senior Notes Due 2028
(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced that it has commenced a private offering of $500 million aggregate principal amount of convertible senior notes due 2028. In connection with this offering, Alnylam expects to grant the initial purchasers of the notes an op - 2025-09-09 00:30:30
ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win
Alnylam and Roche report positive phase II KARDIA-3 results for zilebesiran in high-risk hypertension patients, fueling momentum for a phase III study. - 2025-09-01 11:50:00
Notable ETF Outflow Detected - XBI, ALNY, HALO, INSM
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $119.6 million dollar outflow -- that's a 2.2% decrease week over week - 2025-08-28 11:56:11
Dennis A. Ausiello Sells 31,448 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Dennis A. Ausiello sold 31,448 shares of the company’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $436.58, for a total value of $13,729,567.84. Following the completion of the sale, the director directly owned 911 shares in […] - 2025-08-18 05:14:55
LPL Financial LLC Buys 2,107 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
LPL Financial LLC grew its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 11.3% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,679 shares of the biopharmaceutical company’s stock after acquiring an additional 2,107 shares during the period. LPL Financial LLC’s holdings […] - 2025-08-13 05:04:56
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Cetera Investment Advisers Has $2.17 Million Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Cetera Investment Advisers raised its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 68.1% during the first quarter, Holdings Channel reports. The firm owned 8,017 shares of the biopharmaceutical company’s stock after purchasing an additional 3,247 shares during the period. Cetera Investment Advisers’ holdings in Alnylam Pharmaceuticals were worth $2,165,000 at the end […] - 2025-08-08 04:44:59
Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded at Oppenheimer
Oppenheimer upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Monday, Marketbeat.com reports. The brokerage currently has $490.00 target price on the biopharmaceutical company’s stock. ALNY has been the subject of several other reports. Barclays lifted their price […] - 2025-08-07 02:54:47
Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded by Wolfe Research to Peer Perform Rating
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by equities research analysts at Wolfe Research from an “underperform” rating to a “peer perform” rating in a research report issued on Monday, Marketbeat reports. A number of other brokerages have also recently issued reports on ALNY. Canaccord Genuity Group lifted their price target on shares […] - 2025-08-06 03:02:54
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $400.00 at Chardan Capital
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective lifted by Chardan Capital from $325.00 to $400.00 in a research report report published on Friday,Benzinga reports. Chardan Capital currently has a buy rating on the biopharmaceutical company’s stock. Several other research analysts have also issued reports on ALNY. Needham & Company LLC raised their […] - 2025-08-04 02:48:47
Needham & Company LLC Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $478.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target hoisted by Needham & Company LLC from $377.00 to $478.00 in a research report report published on Thursday morning,Benzinga reports. Needham & Company LLC currently has a buy rating on the biopharmaceutical company’s stock. A number of other research analysts also recently commented on the […] - 2025-08-03 05:28:56
Noteworthy ETF Outflows: XBI, MRNA, ALNY, EXEL
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $225.3 million dollar outflow -- that's a 4.6% decrease week over week - 2025-07-30 11:49:03
Y Intercept Hong Kong Ltd Has $1 Million Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Y Intercept Hong Kong Ltd lessened its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 17.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,720 shares of the biopharmaceutical company’s stock after selling 796 shares during the period. […] - 2025-07-25 06:12:53
Victory Capital Management Inc. Cuts Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Victory Capital Management Inc. lowered its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 5.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,649 shares of the biopharmaceutical company’s stock after selling 2,148 shares during the period. Victory Capital […] - 2025-07-25 05:14:50
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of “Moderate Buy” from Brokerages
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-six research firms that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and twenty-two have assigned a buy recommendation to the […] - 2025-07-24 06:26:55
Alnylam Pharmaceuticals (NASDAQ:ALNY) Now Covered by Truist Financial
Truist Financial initiated coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report sent to investors on Monday, Marketbeat reports. The firm issued a buy rating and a $385.00 price target on the biopharmaceutical company’s stock. A number of other equities research analysts also recently issued reports on ALNY. Jefferies Financial […] - 2025-07-22 03:14:59
Nisa Investment Advisors LLC Cuts Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Nisa Investment Advisors LLC cut its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 38.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,155 shares of the biopharmaceutical company’s stock after selling 5,162 shares during […] - 2025-07-14 05:54:56
Crossmark Global Holdings Inc. Takes Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Crossmark Global Holdings Inc. purchased a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 1,018 shares of the biopharmaceutical company’s stock, valued at approximately $275,000. Other hedge funds have also modified their holdings of the […] - 2025-07-14 05:14:48
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. decreased its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 6.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,691 shares of the biopharmaceutical company’s stock after selling 113 shares during the […] - 2025-07-08 04:40:51
Mirae Asset Global Investments Co. Ltd. Sells 2,596 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Mirae Asset Global Investments Co. Ltd. reduced its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 28.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,534 shares of the biopharmaceutical company’s stock after selling 2,596 shares during the […] - 2025-07-04 04:52:27
Wells Fargo & Company Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $333.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price target lifted by research analysts at Wells Fargo & Company from $287.00 to $333.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the biopharmaceutical company’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside […] - 2025-07-02 03:05:01
Diversified Trust Co Sells 999 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Diversified Trust Co cut its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 40.3% in the first quarter, Holdings Channel reports. The institutional investor owned 1,482 shares of the biopharmaceutical company’s stock after selling 999 shares during the period. Diversified Trust Co’s holdings in Alnylam Pharmaceuticals were worth $400,000 as of […] - 2025-07-01 07:10:56
Sequoia Financial Advisors LLC Boosts Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Sequoia Financial Advisors LLC lifted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 3.0% in the first quarter, HoldingsChannel reports. The fund owned 3,395 shares of the biopharmaceutical company’s stock after acquiring an additional 99 shares during the period. Sequoia Financial Advisors LLC’s holdings in Alnylam Pharmaceuticals were worth $917,000 […] - 2025-07-01 05:22:50
Alnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 12-Month High Following Analyst Upgrade
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) hit a new 52-week high on Monday after Wells Fargo & Company raised their price target on the stock from $287.00 to $333.00. Wells Fargo & Company currently has an equal weight rating on the stock. Alnylam Pharmaceuticals traded as high as $327.05 and last […] - 2025-07-01 02:27:01
Kentucky Retirement Systems Buys New Shares in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Kentucky Retirement Systems bought a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,794 shares of the biopharmaceutical company’s stock, valued at approximately $2,375,000. Several other institutional investors and […] - 2025-06-24 06:20:52

iShares S&P 500 Swap UCITS ETF USD (Dist) ALNY holdings

DateNumber of ALNY Shares HeldBase Market Value of ALNY SharesLocal Market Value of ALNY SharesChange in ALNY Shares HeldChange in ALNY Base ValueCurrent Price per ALNY Share HeldPrevious Price per ALNY Share Held
2025-11-20 (Thursday)-16,689ALNY holding increased by 33378USD -7,439,789ALNY holding increased by 15129413USD -7,439,78933,378USD 15,129,413 USD 445.79 USD 0
2025-11-20 (Thursday)16,689ALNY holding increased by 33378USD 7,439,789ALNY holding increased by 15129413USD 7,439,78933,378USD 15,129,413 USD 445.79 USD 0
2025-11-19 (Wednesday)-16,689ALNY holding increased by 33378USD -7,689,624ALNY holding increased by 15404949USD -7,689,62433,378USD 15,404,949 USD 460.76 USD 0
2025-11-19 (Wednesday)16,689ALNY holding increased by 33378USD 7,689,624ALNY holding increased by 15404949USD 7,689,62433,378USD 15,404,949 USD 460.76 USD 0
2025-11-18 (Tuesday)-16,689ALNY holding increased by 33378USD -7,715,325ALNY holding increased by 15401277USD -7,715,32533,378USD 15,401,277 USD 462.3 USD 0
2025-11-18 (Tuesday)16,689ALNY holding increased by 33378USD 7,715,325ALNY holding increased by 15401277USD 7,715,32533,378USD 15,401,277 USD 462.3 USD 0
2025-11-17 (Monday)-16,689ALNY holding increased by 33378USD -7,685,952ALNY holding increased by 15181983USD -7,685,95233,378USD 15,181,983 USD 460.54 USD 0
2025-11-17 (Monday)16,689ALNY holding increased by 33378USD 7,685,952ALNY holding increased by 15181983USD 7,685,95233,378USD 15,181,983 USD 460.54 USD 0
2025-11-14 (Friday)-16,689ALNY holding increased by 33378USD -7,496,031ALNY holding increased by 15072336USD -7,496,03133,378USD 15,072,336 USD 449.16 USD 0
2025-11-14 (Friday)16,689ALNY holding increased by 33378USD 7,496,031ALNY holding increased by 15072336USD 7,496,03133,378USD 15,072,336 USD 449.16 USD 0
2025-11-13 (Thursday)-16,689ALNY holding increased by 33378USD -7,576,305ALNY holding increased by 15132083USD -7,576,30533,378USD 15,132,083 USD 453.97 USD 0
2025-11-13 (Thursday)16,689ALNY holding increased by 33378USD 7,576,305ALNY holding increased by 15132083USD 7,576,30533,378USD 15,132,083 USD 453.97 USD 0
2025-11-12 (Wednesday)-16,689ALNY holding increased by 33378USD -7,555,778ALNY holding increased by 15098372USD -7,555,77833,378USD 15,098,372 USD 452.74 USD 0
2025-11-12 (Wednesday)16,689ALNY holding increased by 33378USD 7,555,778ALNY holding increased by 15098372USD 7,555,77833,378USD 15,098,372 USD 452.74 USD 0
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ALNY by Blackrock for IE000D3BWBR2

Show aggregate share trades of ALNY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-20BUY33,378467.730445.340 447.579USD 14,939,292 312.87
2025-11-19BUY33,378465.320456.900 457.742USD 15,278,512 312.31
2025-11-18BUY33,378469.110456.270 457.554USD 15,272,237 311.73
2025-11-17BUY33,378463.750449.000 450.475USD 15,035,955 311.16
2025-11-14BUY33,378461.960448.280 449.648USD 15,008,351 310.63
2025-11-13BUY33,378456.140447.155 448.054USD 14,955,130 310.08
2025-11-12BUY33,378459.270447.130 448.344USD 14,964,826 309.53
2025-11-11BUY33,378455.200441.210 442.609USD 14,773,403 308.97
2025-11-10BUY33,378449.680440.930 441.805USD 14,746,567 308.45
2025-11-07BUY33,378443.587430.835 432.110USD 14,422,976 307.93
2025-11-06BUY33,378445.490429.000 430.649USD 14,374,202 307.40
2025-11-05BUY33,378438.530417.000 419.153USD 13,990,489 306.90
2025-11-04BUY33,378431.500421.830 422.797USD 14,112,118 306.44
2025-11-03BUY33,378457.260429.615 432.379USD 14,431,963 305.93
2025-10-31BUY33,378459.570441.220 443.055USD 14,788,290 305.33
2025-10-30BUY27,656471.980436.512 440.059USD 12,170,264 304.75
2025-10-29BUY21,934481.590482.730 482.616USD 10,585,697 304.04
2025-10-28BUY21,934475.910484.610 483.740USD 10,610,353 303.34
2025-10-27BUY21,934478.580485.360 484.682USD 10,631,015 302.63
2025-10-24BUY21,934463.430469.290 468.704USD 10,280,554 301.97
2025-10-23BUY21,934464.000468.860 468.374USD 10,273,315 301.31
2025-10-22BUY21,934464.900480.530 478.967USD 10,505,662 300.64
2025-10-21BUY21,934474.000490.050 488.445USD 10,713,552 299.92
2025-10-20BUY21,934491.220495.550 495.117USD 10,859,896 299.13
2025-10-17BUY21,934481.670492.620 491.525USD 10,781,109 298.37
2025-10-16BUY21,934481.070488.390 487.658USD 10,696,291 297.60
2025-10-15BUY21,934470.270485.280 483.779USD 10,611,209 296.88
2025-10-14BUY21,934469.360479.690 478.657USD 10,498,863 296.15
2025-10-13SELL-21,934464.950473.650 472.780USD -10,369,956 297.25 Loss of -3,850,072 on sale
2025-10-08BUY21,934450.680464.460 463.082USD 10,157,240 296.60
2025-10-07BUY21,934459.580462.630 462.325USD 10,140,637 295.90
2025-10-06BUY21,934452.000458.690 458.021USD 10,046,233 295.23
2025-10-03BUY21,934456.350465.010 464.144USD 10,180,535 294.54
2025-10-02BUY21,934460.990461.530 461.476USD 10,122,015 293.82
2025-10-01BUY21,934460.650467.420 466.743USD 10,237,541 293.09
2025-09-30BUY21,934456.000459.300 458.970USD 10,067,048 292.38
2025-09-29BUY21,934447.490451.630 451.216USD 9,896,972 291.70
2025-09-26BUY21,934446.400453.050 452.385USD 9,922,612 291.02
2025-09-25BUY21,934449.580459.000 458.058USD 10,047,044 290.32
2025-09-24SELL-21,934458.370462.690 462.258USD -10,139,167 291.46 Loss of -3,746,377 on sale
2025-09-18BUY21,934452.170456.940 456.463USD 10,012,060 290.74
2025-09-17BUY21,934451.730463.880 462.665USD 10,148,094 290.02
2025-09-16BUY21,934461.240467.280 466.676USD 10,236,071 289.25
2025-09-15SELL-21,934461.140466.240 465.730USD -10,215,322 290.40 Loss of -3,845,631 on sale
2025-09-12BUY21,934465.890475.690 474.710USD 10,412,289 289.60
2025-09-11BUY21,934468.580474.340 473.764USD 10,391,539 288.79
2025-09-10BUY21,934469.310480.050 478.976USD 10,505,859 287.96
2025-09-09BUY21,934482.130484.210 484.002USD 10,616,100 287.06
2025-09-08BUY21,934455.030463.000 462.203USD 10,137,961 286.29
2025-09-05BUY21,934452.000455.280 454.952USD 9,978,917 285.52
2025-09-04SELL-21,934453.540458.300 457.824USD -10,041,911 286.70 Loss of -3,753,415 on sale
2025-09-02BUY21,934447.000454.500 453.750USD 9,952,553 285.95
2025-08-29BUY21,934446.510453.960 453.215USD 9,940,818 285.19
2025-08-28BUY21,934452.330457.290 456.794USD 10,019,320 284.40
2025-08-27BUY21,934454.180455.450 455.323USD 9,987,055 283.59
2025-08-25BUY22,728443.640458.750 457.239USD 10,392,128 282.82
2025-08-22BUY23,522454.380469.810 468.267USD 11,014,576 282.00
2025-08-21BUY23,522467.550467.710 467.694USD 11,001,098 281.10
2025-08-20BUY23,522458.310466.310 465.510USD 10,949,726 280.24
2025-08-19BUY23,522458.280462.880 462.420USD 10,877,043 279.37
2025-08-18BUY23,522456.870457.920 457.815USD 10,768,725 278.50
2025-08-15SELL-23,522448.910449.520 449.459USD -10,572,174 279.16 Loss of -4,005,824 on sale
2025-08-13BUY23,522432.520438.230 437.659USD 10,294,615 278.40
2025-08-12BUY23,522429.930437.000 436.293USD 10,262,484 277.64
2025-08-11BUY23,522435.000445.200 444.180USD 10,448,002 276.86
2025-08-08BUY23,522438.930439.360 439.317USD 10,333,614 276.04
2025-08-07BUY23,522435.100436.770 436.603USD 10,269,776 275.24
2025-08-06BUY23,522428.140428.690 428.635USD 10,082,353 274.46
2025-08-05BUY23,522418.910426.760 425.975USD 10,019,784 273.73
2025-08-04BUY23,522419.560422.640 422.332USD 9,934,094 272.98
2025-08-01BUY23,522401.800401.800 401.800USD 9,451,139 272.32
2025-07-31BUY23,522392.240402.430 401.411USD 9,441,989 271.69
2025-07-30BUY23,522339.800345.980 345.362USD 8,123,605 271.34
2025-07-29BUY23,522330.550331.060 331.009USD 7,785,994 271.03
2025-07-28SELL-23,522324.790331.430 330.766USD -7,780,278 270.52 Loss of -1,417,075 on sale
2025-07-25BUY23,522328.810331.500 331.231USD 7,791,216 270.21
2025-07-24BUY23,522328.000332.190 331.771USD 7,803,918 269.91
2025-07-23BUY23,522325.640329.340 328.970USD 7,738,032 269.61
2025-07-22BUY23,522325.280326.300 326.198USD 7,672,829 269.31
2025-07-21BUY23,522320.520328.700 327.882USD 7,712,441 269.03
2025-07-18BUY23,522320.530325.620 325.111USD 7,647,261 268.75
2025-07-17BUY23,522324.690329.870 329.352USD 7,747,018 268.45
2025-07-16BUY23,522322.810323.410 323.350USD 7,605,839 268.15
2025-07-15BUY23,522311.120316.900 316.322USD 7,440,526 267.91
2025-07-14BUY23,522315.750319.180 318.837USD 7,499,684 267.64
2025-07-11BUY23,522314.940321.120 320.502USD 7,538,848 267.38
2025-07-10BUY23,522322.640324.820 324.602USD 7,635,288 267.07
2025-07-09BUY23,522320.870322.680 322.499USD 7,585,821 266.77
2025-07-08BUY23,522317.500328.990 327.841USD 7,711,476 266.48
2025-07-07BUY25,468324.130328.240 327.829USD 8,349,149 266.15
2025-07-04BUY27,414 331.910* 265.77
2025-07-03BUY27,414331.910333.700 333.521USD 9,143,145 265.39
2025-07-02BUY27,414329.770330.000 329.977USD 9,045,989 265.01
2025-06-30BUY27,414326.090327.210 327.098USD 8,967,064 264.66
2025-06-27BUY27,414322.830323.200 323.163USD 8,859,191 264.31
2025-06-26BUY27,414318.250325.000 324.325USD 8,891,046 263.99
2025-06-25BUY27,414321.940324.320 324.082USD 8,884,384 263.65
2025-06-24BUY27,414325.000326.030 325.927USD 8,934,963 263.28
2025-06-23BUY27,414313.130314.780 314.615USD 8,624,856 262.98
2025-06-20BUY27,414309.700314.500 314.020USD 8,608,544 262.70
2025-06-19BUY27,414 312.320* 262.40
2025-06-18BUY27,414312.320317.540 317.018USD 8,690,732 262.09
2025-06-17BUY27,414308.710309.060 309.025USD 8,471,611 261.80
2025-06-16BUY27,414308.780309.630 309.545USD 8,485,867 261.51
2025-06-13BUY27,414307.990308.020 308.017USD 8,443,978 261.22
2025-06-12BUY27,414304.670307.480 307.199USD 8,421,554 260.95
2025-06-11BUY27,414298.580303.850 303.323USD 8,315,297 260.71
2025-06-10BUY27,414302.460308.890 308.247USD 8,450,284 260.44
2025-06-09BUY27,414304.000306.170 305.953USD 8,387,396 260.16
2025-06-06BUY27,414300.830310.220 309.281USD 8,478,629 259.90
2025-06-05BUY27,414308.000308.530 308.477USD 8,456,588 259.59
2025-06-04BUY27,414305.310308.930 308.568USD 8,459,083 259.29
2025-06-03BUY27,414303.770307.850 307.442USD 8,428,215 259.00
2025-06-02BUY27,414306.090307.190 307.080USD 8,418,291 258.69
2025-05-30BUY27,414304.560306.000 305.856USD 8,384,736 258.38
2025-05-29BUY27,414292.900293.220 293.188USD 8,037,456 258.15
2025-05-28BUY27,414285.560291.540 290.942USD 7,975,884 257.96
2025-05-27BUY27,414290.100295.440 294.906USD 8,084,553 257.74
2025-05-26BUY27,414 289.960* 257.52
2025-05-23BUY27,414289.960291.220 291.094USD 7,980,051 257.30
2025-05-22BUY27,414289.000291.540 291.286USD 7,985,315 257.08
2025-05-21BUY27,414292.580298.230 297.665USD 8,160,189 256.83
2025-05-20BUY27,414291.680292.990 292.859USD 8,028,436 256.59
2025-05-19BUY27,414291.860296.800 296.306USD 8,122,932 256.34
2025-05-16BUY27,414285.310289.750 289.306USD 7,931,035 256.13
2025-05-15BUY27,414283.400285.000 284.840USD 7,808,604 255.93
2025-05-14BUY27,414267.550270.000 269.755USD 7,395,064 255.85
2025-05-13BUY27,414266.860268.070 267.949USD 7,345,554 255.77
2025-05-12BUY27,414270.190270.200 270.199USD 7,407,236 255.66
2025-05-09BUY27,414251.150260.000 259.115USD 7,103,379 255.70
2025-05-08BUY27,414258.350270.000 268.835USD 7,369,843 255.68
2025-05-07BUY27,414276.550277.850 277.720USD 7,613,416 255.52
2025-05-06BUY27,414269.810276.470 275.804USD 7,560,891 255.41
2025-05-05BUY27,414273.550273.970 273.928USD 7,509,462 255.27
2025-05-02BUY27,414259.390265.000 264.439USD 7,249,331 255.24
2025-05-01BUY27,414255.130265.910 264.832USD 7,260,105 255.24
2025-04-30BUY27,414263.240263.680 263.636USD 7,227,317 255.18
2025-04-29BUY27,414257.190260.540 260.205USD 7,133,260 255.16
2025-04-28BUY27,414254.850256.570 256.398USD 7,028,895 255.16
2025-04-25BUY27,414251.560253.250 253.081USD 6,937,963 255.19
2025-04-24BUY27,414242.610243.690 243.582USD 6,677,557 255.30
2025-04-23BUY27,414241.970248.590 247.928USD 6,796,698 255.40
2025-04-22BUY27,414236.750238.630 238.442USD 6,536,649 255.56
2025-04-21BUY27,414232.750237.770 237.268USD 6,504,465 255.75
2025-04-18BUY27,414 234.560* 255.92
2025-04-17BUY27,414234.560235.120 235.064USD 6,444,044 256.10
2025-04-16BUY27,414230.500234.500 234.100USD 6,417,617 256.32
2025-04-15BUY27,414230.930242.150 241.028USD 6,607,541 256.54
2025-04-14BUY27,414240.010241.830 241.648USD 6,624,538 256.68
2025-04-11BUY27,414237.770240.000 239.777USD 6,573,247 256.84
2025-04-10BUY27,414226.280235.330 234.425USD 6,426,527 257.11
2025-04-09BUY27,414243.270245.560 245.331USD 6,725,504 257.23
2025-04-08BUY27,414224.320246.150 243.967USD 6,688,111 257.53
2025-04-07BUY27,414232.950241.830 240.942USD 6,605,184 257.75
2025-04-04BUY27,414235.740259.160 256.818USD 7,040,409 257.95
2025-04-02BUY27,414266.830267.290 267.244USD 7,326,227 257.87
2025-04-01BUY27,414255.760273.610 271.825USD 7,451,810 257.89
2025-03-31BUY27,414270.020271.850 271.667USD 7,447,479 257.77
2025-03-28BUY27,414268.460271.300 271.016USD 7,429,632 257.67
2025-03-27BUY27,414271.020276.570 276.015USD 7,566,675 257.54
2025-03-19SELL-51,509253.440255.350 255.159USD -13,142,985 256.68 Profit of 78,166 on sale
2025-03-10BUY130,432233.070244.330 243.204USD 31,721,584 257.78
2025-03-07BUY120,863244.520251.120 250.460USD 30,271,347 257.93
2025-02-19BUY51,509250.510254.010 253.660USD 13,065,773 259.66
2025-02-18BUY8,276250.000260.000 259.000USD 2,143,484 259.79
2025-02-14BUY8,276256.450264.870 264.028USD 2,185,096 259.88
2025-02-13BUY8,276264.890268.520 268.157USD 2,219,267 259.81
2025-02-12BUY8,276265.960268.200 267.976USD 2,217,769 259.73
2025-02-11BUY8,276268.990273.230 272.806USD 2,257,743 259.60
2025-02-10BUY8,276274.060276.230 276.013USD 2,284,284 259.40
2025-02-07BUY8,276276.190278.030 277.846USD 2,299,453 259.16
2025-02-06BUY8,276278.250279.240 279.141USD 2,310,171 258.89
2025-02-05BUY8,276276.310278.440 278.227USD 2,302,607 258.64
2025-02-04BUY8,276271.000277.980 277.282USD 2,294,786 258.46
2025-02-03BUY8,276274.550278.510 278.114USD 2,301,672 258.22
2025-01-31BUY8,276271.310279.340 278.537USD 2,305,172 258.02
2025-01-30BUY8,276277.160279.360 279.140USD 2,310,163 257.72
2025-01-29BUY8,276273.990279.700 279.129USD 2,310,072 257.47
2025-01-28BUY8,276279.190283.560 283.123USD 2,343,126 257.12
2025-01-27BUY8,276276.730287.220 286.171USD 2,368,351 256.81
2025-01-24BUY8,276278.760279.670 279.579USD 2,313,796 256.45
2025-01-23BUY8,276275.540277.220 277.052USD 2,292,882 256.13
2025-01-22BUY8,276266.540269.140 268.880USD 2,225,251 255.95
2025-01-21BUY8,276264.990265.020 265.017USD 2,193,281 255.80
2025-01-20BUY8,276 246.270* 255.96
2025-01-17BUY8,276246.270253.500 252.777USD 2,091,982 256.14
2025-01-15BUY8,276251.010255.300 254.871USD 2,109,312 256.36
2025-01-14BUY8,276240.510259.600 257.691USD 2,132,651 256.66
2025-01-13BUY8,276258.270261.860 261.501USD 2,164,182 256.63
2025-01-09BUY8,276 240.550* 257.32
2025-01-08SELL-8,276240.550240.650 240.640USD -1,991,537 259.56 Profit of 156,558 on sale
2025-01-02BUY8,276233.620239.990 239.353USD 1,980,885 260.10
2024-12-31BUY8,276235.310238.440 238.127USD 1,970,739 260.62
2024-12-30BUY8,276236.010236.950 236.856USD 1,960,220 261.16
2024-12-27BUY8,276237.970243.610 243.046USD 2,011,449 261.68
2024-12-26BUY8,276242.500244.820 244.588USD 2,024,210 262.11
2024-12-20BUY8,276245.440247.210 247.033USD 2,044,445 263.38
2024-12-19BUY8,276238.870242.870 242.470USD 2,006,682 264.00
2024-12-18BUY8,276237.920247.050 246.137USD 2,037,030 264.67
2024-12-17BUY8,276246.580249.580 249.280USD 2,063,041 265.14
2024-12-11BUY8,276254.150255.920 255.743USD 2,116,529 266.37
2024-12-10BUY8,276253.910257.990 257.582USD 2,131,749 266.74
2024-12-09BUY8,276255.890258.120 257.897USD 2,134,356 267.07
2024-12-06BUY8,276256.260257.810 257.655USD 2,132,353 267.41
2024-12-05BUY8,276251.810255.290 254.942USD 2,109,900 267.91
2024-12-04BUY8,276254.720256.680 256.484USD 2,122,662 268.35
2024-12-03BUY8,276251.840253.210 253.073USD 2,094,432 268.92
2024-12-02BUY8,276253.010255.290 255.062USD 2,110,893 269.49
2024-11-29BUY8,276253.070254.180 254.069USD 2,102,675 270.10
2024-11-28BUY8,276 253.740* 270.73
2024-11-25BUY8,276250.980255.460 255.012USD 2,110,479 273.18
2024-11-22BUY8,276244.890248.900 248.499USD 2,056,578 274.47
2024-11-21BUY8,276246.800250.710 250.319USD 2,071,640 275.78
2024-11-20BUY8,276248.790249.100 249.069USD 2,061,295 277.13
2024-11-19BUY8,276234.270235.940 235.773USD 1,951,257 279.39
2024-11-12BUY8,276268.950270.770 270.588USD 2,239,386 282.78
2024-11-11SELL-8,276279.820286.580 285.904USD -2,366,141 282.96 Loss of -24,364 on sale
2024-11-08BUY8,276277.430279.510 279.302USD 2,311,503 283.33
2024-11-05BUY8,276265.290268.890 268.530USD 2,222,354 286.62
2024-11-01SELL-8,276273.910274.030 274.018USD -2,267,773 290.29 Profit of 134,642 on sale
2024-10-29BUY11,081284.690287.020 286.787USD 3,177,887 293.60
2024-10-28BUY13,886286.910290.940 290.537USD 4,034,397 294.72
2024-10-23BUY13,886294.870299.170 298.740USD 4,148,304 297.90
2024-10-18SELL-13,886295.930298.940 298.639USD -4,146,901 0.00 Loss of -4,146,901 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ALNY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19216,7273,259396,24354.7%
2025-09-18172,875397386,43244.7%
2025-09-17246,547167472,29252.2%
2025-09-1688,84660226,33639.3%
2025-09-15148,25813,572435,68934.0%
2025-09-12134,122300244,96854.8%
2025-09-11219,8687,820411,70253.4%
2025-09-10543,3267,595916,89859.3%
2025-09-09705,54033,7311,550,89945.5%
2025-09-08175,158440388,71545.1%
2025-09-05127,116335311,25240.8%
2025-09-04110,9302,555236,56846.9%
2025-09-03182,3868,982562,92132.4%
2025-09-02132,77014,416358,47637.0%
2025-08-2993,2162,181276,59433.7%
2025-08-2860,1821,254226,86526.5%
2025-08-27277,6671,084440,57763.0%
2025-08-26243,404919447,42154.4%
2025-08-25156,55115,662374,27641.8%
2025-08-22228,5961,309408,15256.0%
2025-08-21123,9962,862248,30049.9%
2025-08-20149,63813,723316,98347.2%
2025-08-19144,3201,143308,39946.8%
2025-08-18371,31834,264525,78670.6%
2025-08-15104,01813,245265,62039.2%
2025-08-14133,2724,443505,52826.4%
2025-08-13183,2711,3901,017,62318.0%
2025-08-12173,0454,046693,01825.0%
2025-08-11239,1997,600451,24853.0%
2025-08-08168,7553,199466,74436.2%
2025-08-07308,8104,452527,39958.6%
2025-08-06202,15112,590548,34936.9%
2025-08-05256,29513,237826,28331.0%
2025-08-04411,11436,303729,94956.3%
2025-08-01350,06060,108764,94345.8%
2025-07-31829,1916,0231,541,01553.8%
2025-07-30533,88514,703942,78856.6%
2025-07-29164,26855384,53742.7%
2025-07-28150,24069571,96526.3%
2025-07-2590,782429298,80130.4%
2025-07-24132,00111,546286,15546.1%
2025-07-23184,14963312,34059.0%
2025-07-22134,7617,553524,61225.7%
2025-07-21113,303101243,11946.6%
2025-07-1884,1179196,31742.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.